+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
United States Transcatheter Heart Valves Market Outlook to 2033 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR) and Others- Product Image
United States Transcatheter Heart Valves Market Outlook to 2033 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR) and Others- Product Image
New

United States Transcatheter Heart Valves Market Outlook to 2033 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR) and Others

  • PDF Icon

    Report

  • 33 Pages
  • September 2025
  • Region: United States
  • GlobalData
  • ID: 5987340
Description Jump to:
The “United States Transcatheter Heart Valves Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Transcatheter Heart Valves market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR), Transcatheter Pulmonary Valve Replacement (TPVR) and Transcatheter Tricuspid Valve Repair and Replacement

The United States Transcatheter Heart Valves Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Transcatheter Heart Valves Market.
  • Global corporate-level profiles of key companies operating within the United States Transcatheter Heart Valves Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Transcatheter Heart Valves is segmented as follows:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Implantation (TMVI)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Transcatheter Tricuspid Valve Repair and Replacement

Reasons to Buy

The United States Transcatheter Heart Valves Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Transcatheter Heart Valves Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Transcatheter Heart Valves Market, United States
3.1 Transcatheter Heart Valves Market, United States, Revenue ($m), 2018-2033
3.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Transcatheter Heart Valves Market, United States, Volume (Units), 2018-2033
3.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Transcatheter Heart Valves Market, United States, Average Price ($), 2018-2033
3.4 Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Transcatheter Heart Valves Market
4.1 Edwards Lifesciences Corp
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
5 Transcatheter Heart Valves Market Pipeline Products
6 Financial Deals Landscape
6.1 Venture Financing
6.1.1 InterVene Secures USD13 Million in Series A Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.2 Financial Announcements
7.2.1 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
7.2.2 Feb 04, 2025: Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
7.2.3 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.4 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.3 Product News
7.3.1 Sep 24, 2024: New Tricuspid Valve Procedure Helps Patients Avoid Open-Heart Surgery
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Transcatheter Heart Valves Market, United States, Volume (Units), 2018-2033
Table 4: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2018-2033
Table 5: Transcatheter Heart Valves Market, United States, Average Price ($), 2018-2033
Table 6: Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), 2024
Table 7: Transcatheter Heart Valves Market Pipeline Products
Table 8: InterVene Secures USD13 Million in Series A Funding
Table 9: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Transcatheter Heart Valves Market, United States, Volume (Units), 2018-2033
Figure 4: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2018-2033
Figure 5: Transcatheter Heart Valves Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Edwards Lifesciences Corp
  • Medtronic Plc
  • Abbott Laboratories

Related Topics

Related Reports

United States Surgical Heart Valves Market Outlook to 2033 - Cardiac Valve Repair Devices and Prosthetic Heart Valves - Product Image

United States Surgical Heart Valves Market Outlook to 2033 - Cardiac Valve Repair Devices and Prosthetic Heart Valves

  • Report
  • 32 Pages
  • United States
From
Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From
United States Heart Valve Devices Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

United States Heart Valve Devices Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 250 Pages
  • United States
From
North America Heart Valve Devices Market Report and Forecast 2025-2034 - Product Image

North America Heart Valve Devices Market Report and Forecast 2025-2034

  • Report
  • 300 Pages
  • North America
From
Prosthetic Heart Valve Devices and Equipment Market Report 2025 - Product Image

Prosthetic Heart Valve Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Transcatheter Heart Valve Market

The Transcatheter Heart Valve (THV) market is a segment of the Cardiovascular Devices industry. THV devices are used to replace or repair a patient's heart valve without the need for open-heart surgery. This minimally invasive procedure is often used to treat aortic stenosis, a narrowing of the aortic valve. THV devices are typically made of biocompatible materials such as polyester, nitinol, and polyurethane. They are designed to be inserted through a catheter and deployed in the heart. The THV market is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is also driven by the increasing number of clinical trials and the availability of reimbursement policies. Some of the major companies in the THV market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.